Table 1.

Chronic GvHD Cohort

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; JMMoL, juvenile myelomonocytic leukemia; SAA, severe aplastic anemia; FA, Fanconi anemia; GvHD, graft-versus-host disease.

^*standard risk: AML in CR1, ALL in≤CR2, CML in CP.

^†cyclosporine+4 scheduled doses of mini-methotrexate.

^‡cyclosporine alone, or less than 4 scheduled doses of mini-methotrexate.